Form 8-K - Current report:
SEC Accession No. 0001558370-24-012654
Filing Date
2024-09-06
Accepted
2024-09-06 16:15:11
Documents
13
Period of Report
2024-09-04
Items
Item 2.06: Material Impairments

Document Format Files

Seq Description Document Type Size
1 8-K pasg-20240904x8k.htm   iXBRL 8-K 36941
  Complete submission text file 0001558370-24-012654.txt   162446

Data Files

Seq Description Document Type Size
2 EX-101.SCH pasg-20240904.xsd EX-101.SCH 3271
3 EX-101.LAB pasg-20240904_lab.xml EX-101.LAB 16577
4 EX-101.PRE pasg-20240904_pre.xml EX-101.PRE 10457
15 EXTRACTED XBRL INSTANCE DOCUMENT pasg-20240904x8k_htm.xml XML 5008
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

EIN.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39231 | Film No.: 241284684
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)